Please wait while the formulary information is being retrieved.
GYNE-LOTRIMIN (CLOTRIMAZOLE)
- Vulvovaginal candidiasis
- Gyne-lotrimin Vaginal Cream
- Clotrimazole-3 Vaginal Cream
- Clotrimazole 3 Day Vaginal Cream
- 3-day Vaginal Cream
2 % vaginal cream
- Dosage information is not available
2 % vaginal cream
- Dosage information is not available
2 % vaginal cream
- Dosage information is not available
Day 2 % vaginal cream
- Dosage information is not available
3-Day Vaginal 2 % cream
- Dosage information is not available
- None
Contraindicated
- Astagraf Xl
- cyclosporine
- cyclosporine modified
- Gengraf
- Hecoria
- Neoral
- Prograf
- Rapamune
- Sandimmune
- sirolimus
- tacrolimus
- temsirolimus
- Torisel
Severe
Moderate
- isoniazid-rifamp-pyrazinamide
- Mycobutin
- Priftin
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- None
Contraindicated
- None
Severe
Moderate
- None
GYNE-LOTRIMIN (CLOTRIMAZOLE)
- Vulvovaginal candidiasis
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysmenorrhea
- Fever
- Genital organ pruritus
- Vaginal discharge
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- Toxic epidermal necrolysis
- Urticaria
Less Severe
- Abdominal pain with cramps
- Chills
- Contact dermatitis
- Dizziness
- Facial edema
- Flu-like symptoms
- General weakness
- Headache disorder
- Pruritus of skin
- Skin rash
- Vaginal burning
- Vaginal irritation
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Clotrimazole (Vaginal)
Not intended for use age < 12 years per manufacturer.
- 1 Day – 12 Years
- Not intended for use age < 12 years per manufacturer.
Clotrimazole (topical, Vaginal)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Clotrimazole (top,vag)
Poorly absorbed with dermal/vaginal application.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Poorly absorbed with dermal/vaginal application. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Vulvovaginal candidiasis | |
| B37.3 | Candidiasis of vulva and vagina |
| 0-9 | A-Z |
|---|---|
| B37.3 | Candidiasis of vulva and vagina |
Formulary Reference Tool